Evidence map›Paper›PMID 31888951›Full record

ArticleG3 (Bethesda, Md.)2020

A Comprehensive Genome-Wide and Phenome-Wide Examination of BMI and Obesity in a Northern Nevadan Cohort.

Karen A Schlauch, Robert W Read, Vincent C Lombardi, Gai Elhanan, William J Metcalf, Anthony D Slonim, 23andMe Research Team, Joseph J Grzymski

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Precision Medicine and Obesity.Handbook of experimental pharmacology · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Karen A SchlauchInstitute for Health Innovation, Renown Health, Reno, NV.ORCID 0000-0001-6916-8571
Robert W ReadInstitute for Health Innovation, Renown Health, Reno, NV.ORCID 0000-0002-6967-5634
Vincent C LombardiDepartment of Microbiology and Immunology, University of Nevada, School of Medicine, Reno, NV.ORCID 0000-0003-4474-8662
Gai ElhananInstitute for Health Innovation, Renown Health, Reno, NV.
William J MetcalfInstitute for Health Innovation, Renown Health, Reno, NV.
Anthony D SlonimInstitute for Health Innovation, Renown Health, Reno, NV.
23andMe Research Team
Joseph J GrzymskiInstitute for Health Innovation, Renown Health, Reno, NV joeg@dri.edu.ORCID 0000-0003-2646-8958
Renown Health · USUniversity of Nevada, Reno · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aggregation of Electronic Health Records (EHR) and personalized genetics leads to powerful discoveries relevant to population health. Here we perform genome-wide association studies (GWAS) and accompanying phenome-wide association studies (PheWAS) to validate phenotype-genotype associations of BMI, and to a greater extent, severe Class 2 obesity, using comprehensive diagnostic and clinical data from the EHR database of our cohort. Three GWASs of 500,000 variants on the Illumina platform of 6,645 Healthy Nevada participants identified several published and novel variants that affect BMI and obesity. Each GWAS was followed with two independent PheWASs to examine associations between extensive phenotypes (incidence of diagnoses, condition, or disease), significant SNPs, BMI, and incidence of extreme obesity. The first GWAS examines associations with BMI in a cohort with no type 2 diabetics, focusing exclusively on BMI. The second GWAS examines associations with BMI in a cohort that includes type 2 diabetics. In the second GWAS, type 2 diabetes is a comorbidity, and thus becomes a covariate in the statistical model. The intersection of significant variants of these two studies is surprising. The third GWAS is a case

Indexed as

Body Mass IndexGenetic Predisposition to DiseaseGenome-Wide Association StudyAdultAgedComorbidityDatabases, GeneticElectronic Health RecordsFemaleGenetic Association StudiesGenotypeHumansMaleMiddle AgedNevadaObesityBMIGWASObesityPheWAS

Identifiers

PMID31888951
PMCPMC7003082
OpenAlexW2997091875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.